Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Enfermedad de Alzheimer y Demencias

559 ARTÍCULOS , VIENDO DEL 76 AL 90

The Rationale for Radiation Therapy in Alzheimer's Disease

Wilson GD, Rogers CL, Mehta MP, Marples B, Michael DB, Welsh JS, Martinez AA, Fontanesi J.

Radiat Res. 2023 May 1;199(5):506-516. doi: 10.1667/RADE-22-00179.1.

Esmethadone-HCl (REL-1017): a promising rapid antidepressant

Fava M, Stahl SM, De Martin S, Mattarei A, Bettini E, Comai S, Alimonti A, Bifari F, Pani L, Folli F, Guidetti C, Furlan A, Sgrignani J, Locatelli P, Cavalli A, O'Gorman C, Traversa S, Inturrisi CE, Pappagallo M, Manfredi PL.

Eur Arch Psychiatry Clin Neurosci. 2023 Oct;273(7):1463-1476. doi: 10.1007/s00406-023-01571-4. Epub 2023 Mar 8.

Natural Alkaloids as Multi-Target Compounds towards Factors Implicated in Alzheimer's Disease

Vrabec R, Blunden G, Cahlíková L.

Int J Mol Sci. 2023 Feb 23;24(5):4399. doi: 10.3390/ijms24054399.

The Effects of Momordica charantia on Type 2 Diabetes Mellitus and Alzheimer's Disease

Richter E, Geetha T, Burnett D, Broderick TL, Babu JR.

Int J Mol Sci. 2023 Feb 28;24(5):4643. doi: 10.3390/ijms24054643.

Cell Membrane Biomimetic Nanoparticles with Potential in Treatment of Alzheimer's Disease

Zhong X, Na Y, Yin S, Yan C, Gu J, Zhang N, Geng F.

Molecules. 2023 Mar 3;28(5):2336. doi: 10.3390/molecules28052336.

Lecanamab Ushers in a New Era of Anti-Amyloid Therapy for Alzheimer's Disease

Musiek ES, McDade E, Holtzman DM.

Ann Neurol. 2023 May;93(5):877-880. doi: 10.1002/ana.26643. Epub 2023 Mar 29.

Study protocol for a phase III randomised controlled trial of Sailuotong (SLT) for vascular dementia and Alzheimer's disease with cerebrovascular disease

Karamacoska D, Chan DKY, Leung I, Liu JX, Brodaty H, Fahey PP, Bensoussan A, Chang DH.

PLoS One. 2023 Mar 15;18(3):e0265285. doi: 10.1371/journal.pone.0265285. eCollection 2023.

Engineered mesenchymal stem cell-derived extracellular vesicles: A state-of-the-art multifunctional weapon against Alzheimer's disease

Yin T, Liu Y, Ji W, Zhuang J, Chen X, Gong B, Chu J, Liang W, Gao J, Yin Y.

Theranostics. 2023 Feb 5;13(4):1264-1285. doi: 10.7150/thno.81860. eCollection 2023.

An ongoing journey of chalcone analogues as single and multi-target ligands in the field of Alzheimer's disease: A review with structural aspects

Sharma P, Singh M.

Life Sci. 2023 May 1;320:121568. doi: 10.1016/j.lfs.2023.121568. Epub 2023 Mar 15.

Newer modalities in the management of Alzheimer's dementia along with the role of aducanumab and lecanemab in the treatment of its refractory cases

Marsool MDM, Prajjwal P, Reddy YB, Marsool ADM, Lam JR, Nandwana V.

Dis Mon. 2023 May;69(5):101547. doi: 10.1016/j.disamonth.2023.101547. Epub 2023 Mar 15.

Antioxidants: an approach for restricting oxidative stress induced neurodegeneration in Alzheimer's disease

Dubey S, Singh E.

Inflammopharmacology. 2023 Apr;31(2):717-730. doi: 10.1007/s10787-023-01173-5. Epub 2023 Mar 18.

The effectiveness and safety of Jihwang-eumja (Dihuang Yizi) compared to Western medications in patients with Alzheimer's disease: A systematic review and meta-analysis

Kim JY, Lee JY, Jung JH, Park YC, Jung IC.

Complement Ther Clin Pract. 2023 May;51:101746. doi: 10.1016/j.ctcp.2023.101746. Epub 2023 Mar 14.

The potential roles of ATF family in the treatment of Alzheimer's disease

Yang T, Zhang Y, Chen L, Thomas ER, Yu W, Cheng B, Li X.

Biomed Pharmacother. 2023 May;161:114544. doi: 10.1016/j.biopha.2023.114544. Epub 2023 Mar 17.

Nanomedicine-driven therapeutic interventions of autophagy and stem cells in the management of Alzheimer's disease

Alhodieb FS, Rahman MA, Barkat MA, Alanezi AA, Barkat HA, Hadi HA, Harwansh RK, Mittal V.

Nanomedicine (Lond). 2023 Jan;18(2):145-168. doi: 10.2217/nnm-2022-0108. Epub 2023 Mar 20.

Investigating Partially Discordant Results in Phase 3 Studies of Aducanumab

Mallinckrodt C, Tian Y, Aisen PS, Barkhof F, Cohen S, Dent G, Hansson O, Harrison K, Iwatsubo T, Mummery CJ, Muralidharan KK, Nestorov I, Nisenbaum L, Rajagovindan R, von Hehn C, van Dyck CH, Vellas B, Wu S, Zhu Y, Sandrock A, Chen T, Budd Haeberlein S.

J Prev Alzheimers Dis. 2023;10(2):171-177. doi: 10.14283/jpad.2023.6.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias